FIELD: chemistry.
SUBSTANCE: present invention pertains to the method of making compounds with formula , involving reaction of but-2-enoic acid with chlorotrimethylsilane, bromination of the obtained trimethylsilylcrotonate with N-bromosuccinimide, reaction of the obtained trimethylsilyl-4-bromocrotonate or methyl or ethyl 4-bromocrotonate with dimethylamine so as to obtain 4-dimethylaminocrotonic acid, its separation in form of hydrochloride and chlorination with oxalyl chloride. The method allows for obtaining 4-dimethylamino-2-butenoylchloride, suitable for use as an intermediate compound in the synthesis of pharmaceutically active protein kinase inhibitors.
EFFECT: obtaining the agent, suitable for use as an intermediate compound in the synthesis of pharmaceutically active protein kinase inhibitors.
1 cl, 2 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
3-CYANOQUINOLIMES AS INHIBITORS OF EGF-R AND HER2 KINASES | 2002 |
|
RU2309150C2 |
SUBSTITUTED 3-CYANOQUINOLINES | 1998 |
|
RU2202551C2 |
METHOD OF PREPARING 3-HALOGENALKYL-1H- PYRAZOLES | 1996 |
|
RU2169143C2 |
3-PHENYLPYRAZOLE DERIVATIVES, METHOD OF SYNTHESIS OF 3-PHENYLPYRAZOLE DERIVATIVES AND FUNGICIDE COMPOSITION | 1992 |
|
RU2072991C1 |
DIKETONE AS INTERMEDIATE FOR 3-HALOGENE-1H-PYRASOLES | 1996 |
|
RU2251543C2 |
3-(5)-HETEROARYL-SUBSTITUTED PYRAZOLES AS KINASE P38 INHIBITORS | 1998 |
|
RU2249591C2 |
DERIVATIVES OF FIVE-MEMBER HETEROCYCLES, METHOD OF PRODUCTION AND USE THEREOF AS MEDICINAL AGENTS | 2000 |
|
RU2380362C2 |
FIVE-MEROUS HETEROCYCLE DERIVATIVES, METHOD FOR PREPARING AND USING THEM AS THERAPEUTIC AGENTS | 2009 |
|
RU2530882C2 |
AMINOPIRIDAZINOVE COMPOUNDS AS PROTEINKINASE INHIBITORS | 2014 |
|
RU2674701C2 |
HIV-INHIBITING 5-(HYDROXYMETHYLENE- AND AMINOMETHYLENE)SUBSTITUTED PYRIMIDINES | 2007 |
|
RU2452737C2 |
Authors
Dates
2009-02-10—Published
2004-01-16—Filed